Do you have bladder, kidney, prostate, or another genitourinary cancer diagnosis? If so, you may be able to take part in a research study collecting specimens (e.g., blood, urine, saliva, tissue) during your already scheduled appointments. Collecting these specimens may help researchers develop new ways to detect cancer earlier or to more effectively treat cancer.
The purpose of this study is to measure different immmune markers in the nasal lining in healthy patients taking Flonase, an over-the-counter steroid nasal spray.
This study seeks to understand how offering and receiving prenatal screening and diagnosis has changed with abortion legislation changing since July 2022.
Patient-specific information needed to inform decisions and actions (e.g., additional vaccinations, special considerations when sick) about care for adolescents with IBD is often not available at the point of care and decision making. We believe tailored self-management guidance, available to patients and community providers in a plain-language, tabular format, can improve care quality and completion of evidence-based health actions.
The purpose of this study is to adapt a measure of family acceptance and rejection of gender identity.
Our study aims to understand the motivation and attitude of Telehealth participation among doctors.
No guidelines or interventions for patients and their family caregivers exist to support patient adherence to a new medication (venetoclax) and their quality of life. Our research team seeks to understand the real experience and care needs of patients and their family caregivers with the new AML treatment. With the information we learn from this study, we will be able to develop an effective support program for patients with AML and their family caregivers to manage their symptoms at home and improve their quality of life.
To evaluate the efficacy of nipocalimab compared with placebo on reducing the risk of fetal anemia with live neonates in pregnant participants at risk for severe HDFN.
The research study seeks to improve the effectiveness of warnings for little cigars and cigarillos (LCCs) among youth who currently use, have ever used, or are susceptible to using LCCs
This study is testing a new medication for patients who have group 1 PAH.
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
